Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine for treating angina

A technology of angina pectoris and drugs, applied in the field of angina pectoris drugs, can solve the problems of obvious side effects, long cycle, unsatisfactory treatment effect of angina pectoris, etc., and achieve the effect of eliminating angina pectoris and remarkable curative effect

Inactive Publication Date: 2017-05-31
HENAN BALING ELECTRONICS TECH CO LTD
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] The treatment of angina pectoris includes drug therapy, interventional therapy, surgical treatment, rehabilitation of angina pectoris, etc., but in general, the current treatment effect for angina pectoris is not satisfactory, especially the treatment of traditional Chinese medicine, which has a long cycle and often relapses, and has side effects obvious

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0016] A medicine for treating angina pectoris, the main raw materials in parts by weight are: 8 parts of phenobarbital, 17 parts of cannabinoid A, 5 parts of ginkgo ketone ester, 2 parts of isosorbide 5-mononitrate, 11 parts of ibuprofen, 1.5 parts of heparin, 0.5 parts of crospovidone, 8 parts of sodium alginate, and 2 parts of 3-ethyl-(4-aminophenyl)-piperidinedione.

[0017] A preparation method of a medicine for treating angina pectoris, the specific steps are:

[0018] First, in a pharmaceutical-grade clean area, weigh phenobarbital, cannabinoid A, ginkgo ketone ester, 5-isosorbide mononitrate, ibuprofen, heparin, crospovidone, and sodium alginate according to the above metering ratio , 3-ethyl-(4-aminophenyl)-piperidinedione, sieved, mechanically mixed, added ultrapure water, placed in a pharmaceutical mixer, mixed for 4min, controlled RSD ≤ 5%, pressed into tablets after mixing And low temperature drying, the temperature is controlled at 4 ℃, packs and obtains the med...

Embodiment 2

[0020] A medicine for treating angina pectoris, the main raw materials in parts by weight are: 11 parts of phenobarbital, 19 parts of cannabinoid A, 8 parts of ginkgo ketone ester, 2 parts of isosorbide 5-mononitrate, 14 parts of ibuprofen, 1.5 parts of heparin, 0.8 parts of crospovidone, 10 parts of sodium alginate, 2 parts of 3-ethyl-(4-aminophenyl)-piperidinedione.

[0021] A preparation method of a medicine for treating angina pectoris, the specific steps are:

[0022] First, in a pharmaceutical-grade clean area, weigh phenobarbital, cannabinoid A, ginkgo ketone ester, 5-isosorbide mononitrate, ibuprofen, heparin, crospovidone, and sodium alginate according to the above metering ratio , 3-ethyl-(4-aminophenyl)-piperidinedione, sieved, mechanically mixed, added ultrapure water, placed in a pharmaceutical mixer, mixed for 4min, controlled RSD ≤ 5%, pressed into tablets after mixing And low temperature drying, the temperature is controlled at 4 ℃, packs and obtains the medic...

Embodiment 3

[0024] A medicine for treating angina pectoris, the main raw materials in parts by weight are: 15 parts of phenobarbital, 21 parts of cannabinoid A, 9 parts of ginkgo ketone ester, 4 parts of isosorbide 5-mononitrate, 16 parts of ibuprofen, 1.7 parts of heparin, 1.2 parts of crospovidone, 11 parts of sodium alginate, 3 parts of 3-ethyl-(4-aminophenyl)-piperidinedione.

[0025] A preparation method of a medicine for treating angina pectoris, the specific steps are:

[0026] First, in a pharmaceutical-grade clean area, weigh phenobarbital, cannabinoid A, ginkgo ketone ester, 5-isosorbide mononitrate, ibuprofen, heparin, crospovidone, and sodium alginate according to the above metering ratio , 3-Ethyl-(4-aminophenyl)-piperidinedione, sieved, mechanically mixed, added ultrapure water, placed in a pharmaceutical mixer, mixed for 6min, controlled RSD≤5%, pressed into tablets after mixing And low-temperature drying, the temperature is controlled at 6 ℃, and the medicine for treating...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicine for treating angina. The medicine for treating the angina is mainly prepared from, by weight, 8-19 parts of Phenobarbital, 17-25 parts of cannabinoid A, 5-10 parts of a ginkgo biloba extract, 2-6 parts of isosorbide-5-mononitrate, 11-18 parts of ibuprofen, 1.5-1.8 parts of heparin, 0.5-1.9 parts of crospovidone, 8-15 parts of sodium alginate and 2-4 parts of 3-ethyl-(4-aminophenyl)-piperidinedione. The prepared medicine can quickly relieve myocardial ischemia and myocardial infarction angina, the treatment effect is significant, and the angina does not relapse for a long term after being cured.

Description

technical field [0001] The invention relates to the field of medicine preparation, in particular to a medicine for treating angina pectoris. Background technique [0002] Angina pectoris is the main killer of human health. With the acceleration of globalization, cardiovascular and cerebrovascular diseases have begun to spread in developing countries, becoming the number one cause of death in the world. The World Health Organization classifies angina as follows: (1) Asymptomatic myocardial ischemia: also known as painless myocardial ischemia or occult myocardial ischemia, it refers to the objective evidence of myocardial ischemia (cardiac electrical activity, left ventricular Function, myocardial blood perfusion and myocardial metabolism, etc.), but lack of chest pain or subjective symptoms related to myocardial ischemia. (2) Angina pectoris type: refers to a group of clinical syndromes mainly manifested by paroxysmal chest pain or chest discomfort caused by coronary insuffi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/16A61K9/20A61P9/10A61K31/16A61K31/192A61K31/34A61K31/45A61K31/515A61K31/727A61K31/734
CPCA61K36/16A61K9/2004A61K31/16A61K31/192A61K31/34A61K31/45A61K31/515A61K31/727A61K31/734
Inventor 不公告发明人
Owner HENAN BALING ELECTRONICS TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com